Global Biosimilar Supply, Demand and Key Producers, 2026-2032
Description
The global Biosimilar market size is expected to reach $ million by 2032, rising at a market growth of %CAGR during the forecast period (2026-2032).
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original "innovator" products and can manufactured when the original product"s patent expires. Reference to the innovator product is an integral component of the approval.
Unlike with generic drugs of the more common small-molecule type, biologics generally exhibit high molecular complexity and may be quite sensitive to changes in manufacturing processes. Despite that heterogeneity, all biopharmaceuticals, including biosimilar, must maintain consistent quality and clinical performance throughout their lifecycle.
In this report is a biologic defined as proteins, peptides, hormones or antibody’s drugs production by bio-engineered technology, but does not include a vaccine.
China’s core biosimilar players include Qilu Pharmaceutical, Shanghai Henlius and 3SBIO etc. The top 3 companies only hold a share about 61%.
In terms of product, biosimilar monoclonal antibodies is the largest segment, with a share about 85%. And in terms of application, the largest application is cancer，with a share about 50%.
This report studies the global Biosimilar demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biosimilar, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biosimilar that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biosimilar total market, 2021-2032, (USD Million)
Global Biosimilar total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Biosimilar total market, key domestic companies, and share, (USD Million)
Global Biosimilar revenue by player, revenue and market share 2021-2026, (USD Million)
Global Biosimilar total market by Type, CAGR, 2021-2032, (USD Million)
Global Biosimilar total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Biosimilar market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qilu Pharmaceutical, Bio-Thera, Zhejiang Hisun, Shanghai Henlius, Innovent Biologics, Jiangsu Hengrui, Gan&Lee, Tonghua Dongbao, United Laboratory, 3SBIO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Biosimilar market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Biosimilar Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Biosimilar Market, Segmentation by Type:
Biosimilar Monoclonal Antibodies
Biosimilar Insulin
Others
Global Biosimilar Market, Segmentation by Application:
Cancer
Immunological Diseases
Diabetes
Others
Companies Profiled:
Qilu Pharmaceutical
Bio-Thera
Zhejiang Hisun
Shanghai Henlius
Innovent Biologics
Jiangsu Hengrui
Gan&Lee
Tonghua Dongbao
United Laboratory
3SBIO
Luye Pharma
Key Questions Answered
1. How big is the global Biosimilar market?
2. What is the demand of the global Biosimilar market?
3. What is the year over year growth of the global Biosimilar market?
4. What is the total value of the global Biosimilar market?
5. Who are the Major Players in the global Biosimilar market?
6. What are the growth factors driving the market demand?
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original "innovator" products and can manufactured when the original product"s patent expires. Reference to the innovator product is an integral component of the approval.
Unlike with generic drugs of the more common small-molecule type, biologics generally exhibit high molecular complexity and may be quite sensitive to changes in manufacturing processes. Despite that heterogeneity, all biopharmaceuticals, including biosimilar, must maintain consistent quality and clinical performance throughout their lifecycle.
In this report is a biologic defined as proteins, peptides, hormones or antibody’s drugs production by bio-engineered technology, but does not include a vaccine.
China’s core biosimilar players include Qilu Pharmaceutical, Shanghai Henlius and 3SBIO etc. The top 3 companies only hold a share about 61%.
In terms of product, biosimilar monoclonal antibodies is the largest segment, with a share about 85%. And in terms of application, the largest application is cancer，with a share about 50%.
This report studies the global Biosimilar demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biosimilar, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biosimilar that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biosimilar total market, 2021-2032, (USD Million)
Global Biosimilar total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Biosimilar total market, key domestic companies, and share, (USD Million)
Global Biosimilar revenue by player, revenue and market share 2021-2026, (USD Million)
Global Biosimilar total market by Type, CAGR, 2021-2032, (USD Million)
Global Biosimilar total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Biosimilar market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qilu Pharmaceutical, Bio-Thera, Zhejiang Hisun, Shanghai Henlius, Innovent Biologics, Jiangsu Hengrui, Gan&Lee, Tonghua Dongbao, United Laboratory, 3SBIO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Biosimilar market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Biosimilar Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Biosimilar Market, Segmentation by Type:
Biosimilar Monoclonal Antibodies
Biosimilar Insulin
Others
Global Biosimilar Market, Segmentation by Application:
Cancer
Immunological Diseases
Diabetes
Others
Companies Profiled:
Qilu Pharmaceutical
Bio-Thera
Zhejiang Hisun
Shanghai Henlius
Innovent Biologics
Jiangsu Hengrui
Gan&Lee
Tonghua Dongbao
United Laboratory
3SBIO
Luye Pharma
Key Questions Answered
1. How big is the global Biosimilar market?
2. What is the demand of the global Biosimilar market?
3. What is the year over year growth of the global Biosimilar market?
4. What is the total value of the global Biosimilar market?
5. Who are the Major Players in the global Biosimilar market?
6. What are the growth factors driving the market demand?
Table of Contents
111 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Biosimilar Companies Competitive Analysis
- 4 United States VS China VS Rest of World (by Headquarter Location)
- 5 Market Analysis by Type
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
